Guidelines for Manufacturing and Application of Organoids: Liver

Area of Science:

• Biomedical Engineering
• Toxicology
• Drug Development

Background:

• Regulatory frameworks increasingly favor in vitro testing for preclinical drug evaluation and toxicity assessment.
• Advanced liver models are needed to accurately predict drug efficacy and toxicity.
• Liver organoids show promise for drug testing but lack standardized quality evaluation, hindering regulatory approval.

Purpose of the Study:

• To propose comprehensive quality standards for liver organoids.
• To address cell source validation, organoid generation, and functional assessment.
• To enhance the reproducibility and accuracy of in vitro toxicity testing.

Main Methods:

• Development of quality criteria for liver organoids.
• Inclusion of standards for size, cellular composition, and gene expression.
• Incorporation of functional assays for robust hepatotoxicity testing.

Main Results:

• Proposed quality standards cover critical aspects of liver organoid development and assessment.
• Guidelines facilitate the validation of liver organoids for reliable drug efficacy and toxicity predictions.
• Standardization is key to accelerating the adoption of organoids in drug development.

Conclusions:

• Established quality standards are essential for the regulatory acceptance of liver organoids.
• These standards will improve the accuracy and reproducibility of in vitro drug toxicity testing.
• Liver organoids, validated by these standards, can serve as a reliable alternative to animal testing.